サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1302517

コレステロール検査市場：製品タイプ別、検査別、検査タイプ別、処方形態別、エンドユーザー別 - COVID-19/ロシア・ウクライナ紛争/高インフレの累積的影響 - 2023～2030年の世界予測

Cholesterol Testing Market by Product Type, Test, Test Type, Prescription Mode, End-Users - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 180 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
コレステロール検査市場：製品タイプ別、検査別、検査タイプ別、処方形態別、エンドユーザー別 - COVID-19/ロシア・ウクライナ紛争/高インフレの累積的影響 - 2023～2030年の世界予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 180 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のコレステロール検査の市場規模は、2023年に189億7,000万米ドルとなり、CAGR9.64％で大きく成長し、2030年には363億1,000万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界のコレステロール検査市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発・イノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.コレステロール検査の世界市場規模・予測は？

2.予測期間中、世界のコレステロール検査市場を形成するCOVID-19の阻害要因と影響は？

3.コレステロール検査の世界市場において予測期間中に投資すべき製品/セグメント/用途/分野は？

4.コレステロール検査の世界市場における競争戦略は？

5.コレステロール検査の世界市場における技術動向と規制の枠組みは？

6.コレステロール検査の世界市場における主要ベンダーの市場シェアは？

7.コレステロール検査の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 世界中で増加する心血管疾患の有病率
      • 食生活の変化による肥満者数の増加
      • 世界の高齢者人口の急増
    • 抑制要因
      • 可用性と自己検査よりも優先されること・非侵襲的なコレステロール検査が優先されること
    • 機会
      • 政府や民間団体が定期的なコレステロール検査の受診を促すキャンペーンを展開
      • 医療と技術進歩への強力な投資
    • 課題
      • 検査における厳格な規制ポリシー
  • 市場動向
  • COVID-19の累積的影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 コレステロール検査市場：製品タイプ別

  • 検査キット
  • 検査ストリップ

第7章 コレステロール検査市場：検査別

  • 高密度リポタンパク質
  • 低密度リポタンパク質
  • 総コレステロール検査

第8章 コレステロール検査市場：検査タイプ別

  • 侵襲的
  • 非侵襲的

第9章 コレステロール検査市場：処方形態別

  • 店頭
  • 処方箋ベース

第10章 コレステロール検査市場：エンドユーザー別

  • 外来センター
  • クリニック
  • 診断センター
  • 在宅医療
  • 病院

第11章 南北アメリカのコレステロール検査市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第12章 アジア太平洋地域のコレステロール検査市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第13章 欧州・中東・アフリカのコレステロール検査市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第14章 競合情勢

  • FPNVポジショニングマトリックス
  • 市場シェア分析：主要企業別
  • 競合シナリオ分析：主要企業別

第15章 掲載企業一覧

第16章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. CHOLESTEROL TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. CHOLESTEROL TESTING MARKET SIZE, 2022 VS 2030
  • FIGURE 3. CHOLESTEROL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2022 VS 2030 (%)
  • FIGURE 5. CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2022 VS 2030 (%)
  • FIGURE 6. CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2022 VS 2030 (%)
  • FIGURE 7. CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2022 VS 2030 (%)
  • FIGURE 8. CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2022 VS 2030 (%)
  • FIGURE 9. CHOLESTEROL TESTING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 10. CHOLESTEROL TESTING MARKET DYNAMICS
  • FIGURE 11. CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS CHOLESTEROL TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES CHOLESTEROL TESTING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CHOLESTEROL TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CHOLESTEROL TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 20. CHOLESTEROL TESTING MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 21. CHOLESTEROL TESTING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. CHOLESTEROL TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. CHOLESTEROL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 5. CHOLESTEROL TESTING MARKET SIZE, BY TEST KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. CHOLESTEROL TESTING MARKET SIZE, BY TESTING STRIPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 8. CHOLESTEROL TESTING MARKET SIZE, BY HIGH-DENSITY LIPOPROTEIN , BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. CHOLESTEROL TESTING MARKET SIZE, BY LOW-DENSITY LIPOPROTEIN , BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. CHOLESTEROL TESTING MARKET SIZE, BY TOTAL CHOLESTEROL TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. CHOLESTEROL TESTING MARKET SIZE, BY INVASIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. CHOLESTEROL TESTING MARKET SIZE, BY NON-INVASIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 15. CHOLESTEROL TESTING MARKET SIZE, BY OVER THE COUNTER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 18. CHOLESTEROL TESTING MARKET SIZE, BY AMBULATORY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. CHOLESTEROL TESTING MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. CHOLESTEROL TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. CHOLESTEROL TESTING MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. CHOLESTEROL TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS CHOLESTEROL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES CHOLESTEROL TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC CHOLESTEROL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 71. INDIA CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 76. INDONESIA CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 81. JAPAN CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 86. MALAYSIA CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 91. PHILIPPINES CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 96. SINGAPORE CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. SINGAPORE CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 101. SOUTH KOREA CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. SOUTH KOREA CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 106. TAIWAN CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. TAIWAN CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 111. THAILAND CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. THAILAND CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 116. VIETNAM CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. VIETNAM CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA CHOLESTEROL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 127. DENMARK CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. DENMARK CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 132. EGYPT CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. EGYPT CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 137. FINLAND CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. FINLAND CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 142. FRANCE CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. FRANCE CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 147. GERMANY CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. GERMANY CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 152. ISRAEL CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. ISRAEL CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 157. ITALY CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. ITALY CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 162. NETHERLANDS CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. NETHERLANDS CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 167. NIGERIA CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. NIGERIA CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 172. NORWAY CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. NORWAY CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 177. POLAND CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. POLAND CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 182. QATAR CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. QATAR CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 187. RUSSIA CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. RUSSIA CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 192. SAUDI ARABIA CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. SAUDI ARABIA CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 197. SOUTH AFRICA CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH AFRICA CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 202. SPAIN CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. SPAIN CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 207. SWEDEN CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. SWEDEN CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 212. SWITZERLAND CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. SWITZERLAND CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 217. TURKEY CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. TURKEY CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 222. UNITED ARAB EMIRATES CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. UNITED ARAB EMIRATES CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED KINGDOM CHOLESTEROL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED KINGDOM CHOLESTEROL TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM CHOLESTEROL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM CHOLESTEROL TESTING MARKET SIZE, BY PRESCRIPTION MODE, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM CHOLESTEROL TESTING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 232. CHOLESTEROL TESTING MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 233. CHOLESTEROL TESTING MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 234. CHOLESTEROL TESTING MARKET LICENSE & PRICING
目次
Product Code: MRR-434CCDA04D1E

The Global Cholesterol Testing Market is forecasted to grow significantly, with a projected USD 18.97 billion in 2023 at a CAGR of 9.64% and expected to reach a staggering USD 36.31 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Cholesterol Testing Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Cholesterol Testing Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product Type, market is studied across Test Kits and Testing Strips. The Testing Strips is projected to witness significant market share during forecast period.

Based on Test, market is studied across High-Density Lipoprotein, Low-Density Lipoprotein, and Total Cholesterol Test. The High-Density Lipoprotein is projected to witness significant market share during forecast period.

Based on Test Type, market is studied across Invasive and Non-Invasive. The Invasive is projected to witness significant market share during forecast period.

Based on Prescription Mode, market is studied across Over the Counter and Prescription-Based. The Over the Counter is projected to witness significant market share during forecast period.

Based on End-Users, market is studied across Ambulatory Centers, Clinics, Diagnostic Centers, Homecare, and Hospitals. The Hospitals is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Cholesterol Testing Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Cholesterol Testing Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cholesterol Testing Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cholesterol Testing Market?

4. What is the competitive strategic window for opportunities in the Global Cholesterol Testing Market?

5. What are the technology trends and regulatory frameworks in the Global Cholesterol Testing Market?

6. What is the market share of the leading vendors in the Global Cholesterol Testing Market?

7. What modes and strategic moves are considered suitable for entering the Global Cholesterol Testing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Cholesterol Testing Market, by Product Type, 2022 vs 2030
  • 4.3. Cholesterol Testing Market, by Test, 2022 vs 2030
  • 4.4. Cholesterol Testing Market, by Test Type, 2022 vs 2030
  • 4.5. Cholesterol Testing Market, by Prescription Mode, 2022 vs 2030
  • 4.6. Cholesterol Testing Market, by End-Users, 2022 vs 2030
  • 4.7. Cholesterol Testing Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of cardiovascular diseases worldwide
      • 5.1.1.2. Proliferation in number of obese people attributed to changing eating habits
      • 5.1.1.3. Surge in the geriatric population across the globe
    • 5.1.2. Restraints
      • 5.1.2.1. Availability and preference over self-testing and preference for non-invasive cholesterol tests
    • 5.1.3. Opportunities
      • 5.1.3.1. Favorable government and private organization campaigns to undergo regular cholesterol checkups
      • 5.1.3.2. Robust investment in healthcare and technological advancements
    • 5.1.4. Challenges
      • 5.1.4.1. Strict regulatory policies in testing
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Cholesterol Testing Market, by Product Type

  • 6.1. Introduction
  • 6.2. Test Kits
  • 6.3. Testing Strips

7. Cholesterol Testing Market, by Test

  • 7.1. Introduction
  • 7.2. High-Density Lipoprotein
  • 7.3. Low-Density Lipoprotein
  • 7.4. Total Cholesterol Test

8. Cholesterol Testing Market, by Test Type

  • 8.1. Introduction
  • 8.2. Invasive
  • 8.3. Non-Invasive

9. Cholesterol Testing Market, by Prescription Mode

  • 9.1. Introduction
  • 9.2. Over the Counter
  • 9.3. Prescription-Based

10. Cholesterol Testing Market, by End-Users

  • 10.1. Introduction
  • 10.2. Ambulatory Centers
  • 10.3. Clinics
  • 10.4. Diagnostic Centers
  • 10.5. Homecare
  • 10.6. Hospitals

11. Americas Cholesterol Testing Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Cholesterol Testing Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Cholesterol Testing Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. FPNV Positioning Matrix
  • 14.2. Market Share Analysis, By Key Player
  • 14.3. Competitive Scenario Analysis, By Key Player

15. List of Company Mentioned

16. Appendix

  • 16.1. Discussion Guide
  • 16.2. License & Pricing